This week, seven Health Care Provider stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
This week, National Research Corp. (NASDAQ:NRCI) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. National Research provides ongoing survey-based performance measurement, analysis, and tracking services to the healthcare industry. In Portfolio Grader’s specific subcategory of Equity, NRCI also gets an A. For more information, get Portfolio Grader’s complete analysis of NRCI stock.
Patterson (NASDAQ:PDCO) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. Patterson distributes dental products, veterinary supplies for companion pets, and rehabilitation supplies. For more information, get Portfolio Grader’s complete analysis of PDCO stock.
Tenet Healthcare (NYSE:THC) boosts its rating from a B to an A this week. Tenet Healthcare is an investor-owned health care services company that mainly operates general hospitals and related health care facilities, such as outpatient surgery centers, diagnostic imaging centers and a number of medical office buildings. The stock price has risen 5.4% over the past month, better than the 2.6% increase the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of THC stock.
Catamaran Corp (NASDAQ:CTRX) earns an A this week, jumping up from last week’s grade of B. For more information, get Portfolio Grader’s complete analysis of CTRX stock.
AmerisourceBergen (NYSE:ABC) improves from a B to an A rating this week. AmerisourceBergen is a pharmaceutical services company that offers drug distribution and related services to healthcare providers and pharmaceutical manufacturers. For more information, get Portfolio Grader’s complete analysis of ABC stock.
Cardinal Health (NYSE:CAH) shows solid improvement this week. The company’s rating rises from a C to a B. Cardinal Health provides products and services related to the safety and productivity of healthcare. For more information, get Portfolio Grader’s complete analysis of CAH stock.
This week, Healthways’ (NASDAQ:HWAY) ratings are up from a C last week to a B. Healthways provides specialized, comprehensive diabetes and cardiac disease management services to physicians, health plans, and hospitals. Investors seem to agree with the upgraded status of the stock, and have pushed the stock up 15.2% over the past month. For more information, get Portfolio Grader’s complete analysis of HWAY stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.